Lixte Biotechnology Holdings, Inc. - Common Stock (LIXT)
2.4855
+0.0055 (0.22%)
Lixte Biotech Holdings is a biotechnology company focused on the discovery and development of novel therapeutics for the treatment of cancer and other life-threatening diseases
The company specializes in cell death pathways, aiming to identify and advance drug candidates that can effectively target and disrupt these pathways to induce cancer cell death. By leveraging its proprietary technology and research, Lixte seeks to bring innovative solutions to the market, contributing to the advancement of cancer treatment and improving patient outcomes.
Frequently Asked Questions
Is Lixte Biotechnology Holdings, Inc. - Common Stock publicly traded?
Yes, Lixte Biotechnology Holdings, Inc. - Common Stock is publicly traded.
What exchange does Lixte Biotechnology Holdings, Inc. - Common Stock trade on?
Lixte Biotechnology Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lixte Biotechnology Holdings, Inc. - Common Stock?
The ticker symbol for Lixte Biotechnology Holdings, Inc. - Common Stock is LIXT on the Nasdaq Stock Market
What is the current price of Lixte Biotechnology Holdings, Inc. - Common Stock?
The current price of Lixte Biotechnology Holdings, Inc. - Common Stock is 2.486
When was Lixte Biotechnology Holdings, Inc. - Common Stock last traded?
The last trade of Lixte Biotechnology Holdings, Inc. - Common Stock was at 9:57 am EST on January 31st, 2025
What is the market capitalization of Lixte Biotechnology Holdings, Inc. - Common Stock?
The market capitalization of Lixte Biotechnology Holdings, Inc. - Common Stock is 5.59M
How many shares of Lixte Biotechnology Holdings, Inc. - Common Stock are outstanding?
Lixte Biotechnology Holdings, Inc. - Common Stock has 2.25M shares outstanding.